Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence – Drugs Related: RCT: Early treatment with fluvoxamine reduced the risk of emergency care and hospitalization among patients with COVID-19. [Preprint] RCT: Fluvoxamine reduced the risk for ER visits and hospitalization among patients with Covid-19. Opinion | Could this be our first […]

The post Fluvoxamine for the early treatment of SARS-CoV-2 Infection: a review of current evidence. appeared first on Links Medicus.